1. Feng S, Wang J, Yin C, et al. The association between lower extremity function and cardiovascular diseases risk in older Chinese adults: Longitudinal evidence from a nationwide cohort. Arch Gerontol Geriatr 2024;124:105463.

2. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995;332:556–561.

3. Rodrigues F, Domingos C, Monteiro D, Morouço P. A review on aging, sarcopenia, falls, and resistance training in community-dwelling older adults. Int J Environ Res Public Health 2022;19:874.

4. Peoples BM, Harrison KD, Santamaria-Guzman KG, Campos-Vargas SE, Monaghan PG, Roper JA. Functional lower extremity strength influences stepping strategy in community-dwelling older adults during single and dual-task walking. Sci Rep 2024;14:13379.

5. Florence CS, Bergen G, Atherly A, Burns E, Stevens J, Drake C. Medical costs of fatal and nonfatal falls in older adults. J Am Geriatr Soc 2018;66:693–698.

6. Smith ML, Ory MG. Multi-directional nature of falls among older adults: a rationale for prevention and management. Front Public Health 2023;11:1117863.

7. Ryan M, Rössler R, Rommers N, et al. Lower extremity physical function and quality of life in patients with stroke: a longitudinal cohort study. Qual Life Res 2024;33:2563–2571.

8. Kim BJ, Ha K, Kim HS, Bae HR, Son M. Associations of depressive symptoms with lower extremity function and balance in Korean older adults. Epidemiol Health 2024;46:e2024021.

9. Volpato S, Blaum C, Resnick H, Ferrucci L, Fried LP, Guralnik JM Women’s Health and Aging Study. Comorbidities and impairments explaining the association between diabetes and lower extremity disability: the Women’s Health and Aging Study. Diabetes Care 2002;25:678–683.

10. Kraut JA, Madias NE. Metabolic acidosis of CKD: an update. Am J Kidney Dis 2016;67:307–317.

11. Cheng TC, Huang SH, Kao CL, Hsu PC. Muscle wasting in chronic kidney disease: mechanism and clinical implications-a narrative review. Int J Mol Sci 2022;23:6047.

12. Dhondup T, Qian Q. Acid-base and electrolyte disorders in patients with and without chronic kidney disease: an update. Kidney Dis (Basel) 2017;3:136–148.

13. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 2024;105(4S):S117–S314.

14. Roshanravan B, Robinson-Cohen C, Patel KV, et al. Association between physical performance and all-cause mortality in CKD. J Am Soc Nephrol 2013;24:822–830.

15. Agrawal V, Marinescu V, Agarwal M, McCullough PA. Cardiovascular implications of proteinuria: an indicator of chronic kidney disease. Nat Rev Cardiol 2009;6:301–311.

16. Paisley KE, Beaman M, Tooke JE, Mohamed-Ali V, Lowe GD, Shore AC. Endothelial dysfunction and inflammation in asymptomatic proteinuria. Kidney Int 2003;63:624–633.

17. Kuusniemi AM, Lapatto R, Holmberg C, Karikoski R, Rapola J, Jalanko H. Kidneys with heavy proteinuria show fibrosis, inflammation, and oxidative stress, but no tubular phenotypic change. Kidney Int 2005;68:121–132.

18. Chronic Kidney Disease Prognosis Consortium; Matsushita K, van der Velde M, et al.; Astor BC. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375:2073–2081.

19. Seong SC, Kim YY, Park SK, et al. Cohort profile: the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) in Korea. BMJ Open 2017;7:e016640.

20. Stevens LA, Schmid CH, Greene T, et al. Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis 2010;56:486–495.

21. Hsiao SM, Tsai YC, Chen HM, et al. Association of fluid status and body composition with physical function in patients with chronic kidney disease. PLoS One 2016;11:e0165400.

22. Anantha-Narayanan M, Sheikh AB, Nagpal S, et al. Systematic review and meta-analysis of outcomes of lower extremity peripheral arterial interventions in patients with and without chronic kidney disease or end-stage renal disease. J Vasc Surg 2021;73:331–340.e4.

23. Lee YL, Jin H, Lim JY, Lee SY. Relationship between low handgrip strength and chronic kidney disease: KNHANES 2014-2017. J Ren Nutr 2021;31:57–63.

24. Saito A, Hiraki K, Otobe Y, Izawa KP, Sakurada T, Shibagaki Y. Relationship between serum vitamin D and leg strength in older adults with pre-dialysis chronic kidney disease: a preliminary study. Int J Environ Res Public Health 2020;17:1433.

25. Hyun YY, Lee KB, Rhee EJ, Park CY, Chang Y, Ryu S. Chronic kidney disease and high eGFR according to body composition phenotype in adults with normal BMI. Nutr Metab Cardiovasc Dis 2016;26:1088–1095.

26. Toyama T, van den Broek-Best O, Ohkuma T, et al. Associations of impaired renal function with declines in muscle strength and muscle function in older men: findings from the CHAMP study. J Gerontol A Biol Sci Med Sci 2019;74:1812–1820.

27. Tomaszewski M, Charchar FJ, Maric C, et al. Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int 2007;71:816–821.

28. Helal I, Fick-Brosnahan GM, Reed-Gitomer B, Schrier RW. Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol 2012;8:293–300.

29. Tonneijck L, Muskiet MH, Smits MM, et al. Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment. J Am Soc Nephrol 2017;28:1023–1039.

30. Pugliese G, Solini A, Bonora E, et al. The chronic kidney disease Epidemiology Collaboration (CKD-EPI) equation provides a better definition of cardiovascular burden associated with CKD than the Modification of Diet in Renal Disease (MDRD) Study formula in subjects with type 2 diabetes. Atherosclerosis 2011;218:194–199.

31. Miettinen H, Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke 1996;27:2033–2039.

32. Baxmann AC, Ahmed MS, Marques NC, et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol 2008;3:348–354.